Airfinity key facts
as of Oct 2026- Developer of a health technology platform designed to provide global health intelligence and analytics.
- Airfinity is valued at approximately $69.4M as of Oct 2026 (last reported valuation).
- It has raised $12.6M; the latest was Later Stage VC in Oct 2025.
- Notable investors include In-Q-Tel, The FSE Group, British Business Bank, Gresham House Asset Management, Baronsmead — 8 tracked in total.
- Status: Privately Held (backing).
Airfinity's last reported valuation, Oct 2022. Nothing priced has surfaced since.
- ·Watch Airfinity: the Monday email on marks, rounds and moves
Airfinity funding rounds
No funding rounds for Airfinity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Airfinity valuation
Airfinity's last reported valuation was $69.4 million in Oct 2022. No priced round, secondary trade or fund mark has surfaced since.
Airfinity investors
8 investors are on record for Airfinity, including In-Q-Tel, The FSE Group, British Business Bank and Gresham House Asset Management.
About Airfinity
Developer of a health technology platform designed to provide global health intelligence and analytics. The company's platform offers proprietary surveillance tools and forecast models with analysis for dozens of infectious diseases, including COVID, influenza, and respiratory syncytial virus (RSV), enabling pharmaceuticals, governments, and investors to understand and make decisions rapidly to save lives.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2015
- Employees
- 77
- Website
- airfinity.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.